Semaglutide for Post-Smoking Cessation Weight Management
Status:
Recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
This trial will examine the effect of semaglutide 2.4mg on changes in body weight, body
composition, and peripheral and central mechanisms that control appetite, satiety, and food
intake in the context of smoking cessation.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston